UroGen Pharma Ltd. URGN

Set alert

28.74 USD -5.66 (-16.45%)

At closeNov 4, 2026, 5:30 PM EST

28.74 0.00 0.00%

After hours · Nov 4, 5:30 PM ET

27.55 Day range 34.17

16.50 52-week range 50.81

Held by insiders 3.49%

Held by institutions 98.22%

Float held by institutions 101.77%

Institutions 272

Top institutional holders
Holder	% held	Shares	Value	Reported
RTW Investments LP	9.30%	4,543,895	130.59M	Jun 29, 2026
Blackrock Inc.	6.55%	3,201,461	92.01M	Jun 29, 2026
Morgan Stanley	5.27%	2,576,363	74.04M	Jun 29, 2026
Kynam Capital Management, LP	4.98%	2,434,207	69.96M	Jun 29, 2026
Jefferies Financial Group Inc.	4.50%	2,199,652	63.22M	Jun 29, 2026
SG Americas Securities, LLC	4.20%	2,052,906	59.00M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
iShares Trust-iShares Russell 2000 ETF	2.26%	1,103,214	31.71M	Sep 29, 2026
American Century Mutual Funds, Inc.-Small Cap Growth Fund	1.79%	874,981	25.15M	Sep 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	0.95%	466,099	13.40M	Aug 30, 2026
iShares Trust-iShares Russell 2000 Growth ETF	0.70%	343,762	9.88M	Sep 29, 2026
iShares Trust-iShares Biotechnology ETF	0.66%	323,796	9.31M	Sep 29, 2026
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund	0.50%	244,145	7.02M	Aug 30, 2026

URGN insiders
Insider	Relation	Latest transaction	Date	Shares held
BUTITTA CYNTHIA M	Director	Conversion of Exercise of derivative security	Nov 25, 2025	2,000
DEGNAN CHRISTOPHER	Chief Financial Officer	Sale	Oct 7, 2025	2,280
HOLDEN STUART M.D.	Director	Conversion of Exercise of derivative security	Nov 25, 2025	2,000
ROBINSON JAMES A JR.	Director	Conversion of Exercise of derivative security	Aug 25, 2026	8,000
SCHOENBERG MARK	Officer	Sale	Sep 7, 2026	59,882
SMITH JASON DREW	General Counsel	Sale	Sep 7, 2026	53,141

Held by funds